Replies to post #72014 on Ayala Pharmaceuticals Inc (ADXS)

[Chemist823]

"The findings presented suggest that ADXS-NEO generates T-cell responses against cancer proteins, even when they were identified as “non-immunogenic” (that do not generate immune responses) using conventional methods."
First patient dosed, exciting days ahead.

[fbg0316]

Agree Blue, interesting that both NEO and HOT are targeting small cell lung cancer. I can't imagine Amgen letting a competitor partner with ADXS on HOT for the same indication NEO is going after. My guess is we'll see a HOT deal with Amgen announced shortly. It would make sense. Both NEO and HOT are cutting-edge, next generation therapies, so Amgen may want to test them in parallel comparing the same target.

[rmarc]

" My buddy says they`d rather pay 5 times more for a proven concept,then pay chump for it prematurely.".. Your buddy is a very dim bulb.

[girlfriend]

“My buddy”

Yawn...